Biocon Acquisition - Summary of Total Consideration (Details) (Parenthetical) - Biocon Acquisition [Member] $ in Thousands	9 Months Ended
	Sep. 30, 2019 USD ($)
Total consideration	$ 1,632	[1]
Accrued expenses	5
Working capital payments	137
Fair value of contingent consideration liabilities	499
Upfront payment	991
Held in escrow	$ 250

[1] Total consideration of $1,632,000 consists of $5,000 in accrued expenses, $137,000 in working capital payments, $499,000 of contingent consideration liabilities, and an upfront payment of $991,000, of which $250,000 is held in escrow.